Therabel International is a privately-owned pharmaceutical company with a European heritage dating back to 1945. They have achieved extensive international expansion through acquisitions and organic growth. Therabel's business model and corporate culture are centered around the value of partnership.

They collaborate closely with other pharmaceutical companies, sharing their expertise and fostering operational excellence. Therabel's product portfolio is primarily generated through collaborations, ensuring a high level of commitment and focus on their partnered products. They aim to provide safe and effective therapeutic solutions to European healthcare professionals and patients through their expertise in market access and commercialization.

Therabel is committed to strict compliance with industry regulations, ensuring the highest quality standards and social responsibility. Their human-scale business structure and corporate culture allow for personalized contact and dynamic implementation of innovative approaches. With a focus on medium to long-term objectives, Therabel aims to become one of the leading partnership-driven pharmaceutical companies in Europe while remaining dedicated to their ethics, independence, and human-scale structure